Clinical Trials
Replimune Provides Update on RP1 Clinical Development Program in Cutaneous Squamous Cell Carcinoma
Replimune Group Inc. , a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic platform, announced that the first patient has been enrolled in...
Press Releases
Alexion and Stealth Announce Agreement for develop and Commercialize Late Stage Therapy for Mitochondrial Diseases
Alexion Pharmaceuticals, Inc. and Stealth BioTherapeutics Corp announced an agreement for an option to co-develop and commercialize elamipretide for mitochondrial diseases. Currently being evaluated in...
Drug Research
U.S. FDA approves rivaroxaban to help prevent blood clots in acutely ill medical patients
Bayer AG and its development partner Janssen Research & Development, LLC announced that the U.S. FDA has approved rivaroxaban (Xarelto) for the prevention of venous...
Packaging & Labelling
Romaco and Huhtamaki at the CPhI in Frankfurt
At the upcoming CPhI Worldwide in Frankfurt (Germany), Romaco and Huhtamaki will show the first recyclable strip packaging for pharmaceutical solids. An HM 1-230 heat-sealing...
Press Releases
Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-LRx
Akcea Therapeutics, Inc. , a majority-owned affiliate of Ionis Pharmaceuticals, Inc. and Pfizer Inc. , announced that the companies have entered into a worldwide exclusive...
Press Releases
GSK and Lyell Immunopharma join forces to develop the next generation of cancer cell therapies
GlaxoSmithKline plc announced a five-year collaboration with Lyell Immunopharma, a San Francisco biotechnology company, to develop new technologies to improve cell therapies for cancer patients....
Press Releases
The University of Bristol Selects Signant Health’s TrialConsent to Assess the Impact and Value of eConsent in an Oncology Trial
The National Institute for Health Research Bristol Biomedical Research Centre (NIHR Bristol BRC) at the University of Bristol has selected Signant Health, formerly CRF Health...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.